期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

^(18)F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用 被引量：1

^(18)F-FDG PET and PET-CT imaging in lymphoma
下载PDF
导出
摘要 PET在淋巴瘤的分期、再分期、疗效评价及预后判断中具有重要价值,PET-CT则集中了PET的功能显像与CT的解剖显像的双重优势,对淋巴瘤病灶的定位、定性诊断的准确性更高。 PET imaging plays an important role in staging, restaging, evaluating the treatment effects and the prognosis of the lymphoma. PET-CT realized the fuse of functional and anatomic imaging in one gantry and showed more values in clinical diagnosis. It makes the location and characterization of the lesions more accurate.
作者 华逢春 管一晖 赵军
机构地区 复旦大学附属华山医院PET中心
出处 《国外医学（放射医学核医学分册）》 2005年第5期216-219,226,共5页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
关键词 正电子发射体层显像 计算机体层成像 18F-氟代脱氧葡萄糖 淋巴瘤 positron emission tomography computed tomography ^18F-fluorodeoxyglucose lymphoma
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1Schoder H, Meta J, Yap C, et al. Effect of whole-body 18F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma[J]. J Nucl Med, 2001, 42(8):1139-1143.
  • 2Schaefer NG, Hany TF, Taverna C, et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging-do we need contrast-enhanced CT? [J]. Radiology, 2004,232(3): 823-829.
  • 3Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography [J].Blood, 1998, 91(9): 3340-3346.
  • 4Moog F, Bangerter M, Kotzerks J, et al. 18F-fluorodeoxyglucose positron emission tomography as a new approach to detect lymphomatous bone marrow[J]. J Clin Oncol, 1998, 16(2): 603-609.
  • 5Romer W, Hanauske AR, Ziegler S, et al. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose[J]. Blood, 1998, 91(12): 4464-4471.
  • 6Mikhaeel NG, Timothy AR, O'Doherty MJ, et al. 18F-FDG PET as a prognostic indicator in the treatment of aggressive non-Hodgkins lymphoma:comparison with CT[J]. Leuk Lymphoma,2000, 39(5-6):543-553.
  • 7Jerusalem G, Beguin Y, Fassotte MF, et al. Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma [J]. Haematologica,2000, 85(6): 613-618.
  • 8Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of positron emission tomography with Fluorine-18 Fluorodeoxyglucose ([18F]-FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: [18F]FDG-PET a valid alternative to conventional diagnostic methods?[J]. J Clin Oncol, 2001, 19(2): 414-419.
  • 9Weihrauch MR, Re D, Scheidhauer K, et al. Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease[J]. Blood, 2001, 98(10): 2930-2934.
  • 10Kostakoglu L, Coleman M, Leonard JP, et al. PET predicts prognosis after one cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease[J]. J Nucl Med, 2002, 43(8): 1018-1027.

同被引文献5

  • 1Schiepers C,Filmont J,Czernin J. PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma[J].European Journal of Nuclear Medicine and Molecular Imaging,2003,(Suppl 1):S82-S88.
  • 2Lee YK,Cook G,Flower MA. Addition of 18F-FDG-PET scan to radiotherphy planning of thoracic Iymphoma[J].Radiotherapy and Oncology,2004.277-283.
  • 3Hutchings M,Loft A,Hansen M. Clinical impact of FDG-PET/CT in the planning of radiotheraphy for early-stage Hodgkin lymphoma[J].European Journal of Haematology,2007.206-212.
  • 4Juweid ME. Utility of positron emission tomography(PET)scanning managing patients with Hodgkin lymphoma[M].Florida:Orlando,2006.259-265.
  • 5王艳丽,崔新建.PET-CT在肺癌诊断及分期中的应用进展[J].齐鲁医学杂志,2009,24(1):90-91. 被引量：9

引证文献1

国外医学（放射医学核医学分册）
2005年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部